Eisai (perusahaan): Perbedaan antara revisi
Konten dihapus Konten ditambahkan
k Bot: Penggantian teks otomatis (- + ) |
|||
Baris 1:
{{Infobox Perusahaan|name=Eisai Co., Ltd.|logo=File:Ēzai-Logo.svg|type=[[perusahaan publik|Publik]] [[Kabushiki kaisha|KK]]|traded_as={{TYO|4523}}<br>[[Topix|TOPIX Large 70 Component]]<br>[[Topix|TOPIX 100 Component]]<br>[[Nikkei 225|Nikkei 225 Component]]|industry=[[Perusahaan farmasi|Farmasi]]|foundation=({{Start date and age|1941|12|06}})|founder=Toyoji Naito|hq_location=4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Jepang|location=4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Jepang|key_people=Haruo Naito<br><small>([[President (corporate title)|President]] and [[CEO]])</small>|products={{unbulleted list|[[Eribulin|Halaven]]|[[Donepezil|Aricept]]|[[Rabeprazole|Pariet]]|[[Banzel]]|[[Zonisamide#History|Zonegran]]|[[Perampanel|Fycompa]]|[[Eslicarbazepine acetate|Zebinix]]}}|revenue={{increase}} [[US dollar|US$]] 5.82 miliar ([[Tahun fiskal|TF]] 2013) ([[Yen|JPY]] 600.4 miliar) (TF 2013)|net_income={{increase}} US$ 320 juta (TF 2013) (JPY 33 miliar) (
== Sejarah ==
|